1. Anderson, R.W., W.H. Puckett, W.J. Dana, T.V. Nguyen, J.C. Theiss, and T.S. Matney. 1982. Risk of handling injectable antineoplastic agents. Am. J. Hosp. Pharm. 39:1881–1887.
2. Aronson, M.M., R.C. Miller, R.B. Hill, W.W. Nichols, and A.T. Meadows. 1982. Acute and long-term cytogenetic effects of treatment of childhood cancer: Sister- chromatid exchanges and chromosome aberrations. Mutat. Res. 92:291–307.
3. Au, W., O.I. Sokova, B. Kopnin, and F.F. Arrighi. 1980. Cytogenetic toxicity of cyclophosphamide and its metabolites in vitro. Cytogenet. Cell Genet. 26:108–116.
4. Berlin, A., M. Draper, K. Hemminki, and H. Vainio, eds. (in press). Monitoring of Human Exposure to Carcinogenic and Mutagenic Agents. lARC Scientific Publication No. 59, International Agency for Research on Cancer: Lyon, France.
5. Bos, R.P., A.O. Leenars, J.L.G. Theuws, and P.Th. Henderson. 1982. Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking. Int. Arch. Occup. Environ. Health 50:359–369.